APA (7th ed.) Citation

MP, J., EA, R., AM, S., K, R., MP, L., FG, R., . . . EM, B. (2012). High miR-26a and low CDC2 levels associate with decreased EZH2 expression and with favorable outcome on tamoxifen in metastatic breast cancer. Breast cancer research and treatment, 133(3), 937. https://doi.org/10.1007/s10549-011-1877-4

Chicago Style (17th ed.) Citation

MP, Jansen, et al. "High MiR-26a and Low CDC2 Levels Associate with Decreased EZH2 Expression and with Favorable Outcome on Tamoxifen in Metastatic Breast Cancer." Breast Cancer Research and Treatment 133, no. 3 (2012): 937. https://doi.org/10.1007/s10549-011-1877-4.

MLA (9th ed.) Citation

MP, Jansen, et al. "High MiR-26a and Low CDC2 Levels Associate with Decreased EZH2 Expression and with Favorable Outcome on Tamoxifen in Metastatic Breast Cancer." Breast Cancer Research and Treatment, vol. 133, no. 3, 2012, p. 937, https://doi.org/10.1007/s10549-011-1877-4.